Table 1.
Baseline characteristics
| Patient number | Gender | Age | Symptoms | Scadding stage | EPM | HLA DRB1* |
|---|---|---|---|---|---|---|
| 1 | M | 41 | skin, dyspnea | 3 | skin | 15/15 |
| 2 | F | 52 | kidney stone | 3 | spleen, bone marrow, hypercalciuri, kidney stone | 04/07 |
| 3 | M | 49 | dyspnea | 3 | 04/15 | |
| 4 | M | 58 | cough | 2 | 14/15 | |
| 5 | M | 51 | no symptoms | 2 | 04/08 | |
| 6 | F | 55 | dyspnea | 1 | 01/14 | |
| 7 | M | 38 | skin, cough | 2 | skin | 11/15 |
| 8 | M | 43 | cough | 2/3 | 13/15 | |
| 9 | M | 60 | cough, dyspnea | 2 | 03/13 | |
| 10 | M | 49 | cough | 2 | liver | 11/13 |
| 11 | M | 30 | eye | 1 | eye | 04/14 |
| 12 | M | 40 | cough | 1 | peripheral lymph nodes | 11/13 |
Patient number 5 had no symptoms related to sarcoidosis but searched health care because of pain in the left groin and scrotum. CT could not reveal any abnormality in that region but in the lung parenchyma. Scadding stage = radiographic extent of sarcoidosis assessed by chest X-ray (0–4), EPM = extrapulmonary manifestations, F = female, M = male, HLA = human leucocyte antigen.